studyrandomized trial
Celecoxib in Reducing Cognitive Impairment with Neoadjuvant Chemotherapy or Definitive Chemoradiation for Head and Neck Carcinoma (CELCI-HN): A Phase II Randomized Trial
Research Square · 7h ago
Untick a publication to hide it; your selections are stored in this browser. Journals, preprint servers, consumer brands and other high-volume feeds are off by default.
Medicine & Biotech · covered by 1 outlet this week · tracked since 2026-11-11
Press: 1 independent outlet-days